Top Cardiology Conferences in 2026: A Strategic Guide for Industry Leaders
The events you attend in 2026 determine whose priorities you understand, whose trust you earn, and whether the relationships you build translate into lasting partnerships. This guide covers the most relevant cardiology conferences of 2026 for healthcare industry executives: the ones worth your time, your travel budget, and your organization's focus.
The Best Cardiology Conferences of 2026
THMA Cardiovascular Forum 2026
Dates and Location: Spring: May 6–8, 2026 | Fort Lauderdale, FL Fall: September 16–18, 2026 | Boston, MA
Who It Is For: Healthcare technology, medical device, pharmaceutical, and services organizations whose solutions intersect with cardiovascular care delivery. Attendees typically include CEOs, Chief Growth Officers, and strategy and product leaders who need direct, substantive access to the health system executives governing cardiovascular service line strategy.
Why It Stands Out in 2026: Cardiovascular service lines are navigating a demanding set of pressures simultaneously: site-neutral payment reform, the integration of AI and predictive analytics into care workflows, the expansion of ambulatory surgical centers, and growing demand for remote patient monitoring programs that extend care beyond hospital walls. The THMA Cardiovascular Forum places industry leaders in the same room as Cardiovascular System Service Line Leaders and heads of function from nationally recognized systems including Mayo Clinic, Yale New Haven Health, Northwell Health, Cleveland Clinic, Intermountain Health, and Cedars-Sinai, among others.
Groups are kept deliberately small. The format is retreat-style, and a strict 1:1 health system-to-industry ratio ensures that discussion remains substantive rather than transactional. Recent agenda topics have included AI and analytics in cardiovascular care, ambulatory strategy and ASC excellence, remote patient monitoring and workforce optimization, and the downstream effects of federal policy and reimbursement changes. These are closed-door peer conversations that surface the unfiltered strategic and operational realities shaping cardiovascular decision-making at major health systems.
Best Suited For: Pharma and biotech companies whose cardiovascular therapies require alignment with cardiovascular leadership on access, implementation, or care model fit. Also valuable to industry organizations in cardiovascular devices, imaging technology, care navigation software, remote monitoring platforms, and AI-enabled clinical solutions, whose commercial strategy depends on understanding and engaging the health system executives who govern cardiovascular program direction.
THMA Pharmacy Growth Collaborative 2026
Dates and Location: Spring: June 3–5, 2026 | Carlsbad, CA Fall: October 14–16, 2026 | Boston, MA
Who It Is For: Pharmaceutical commercial, market access, and managed care teams, as well as health technology and services organizations whose solutions intersect with specialty pharmacy, infusion care, formulary management, or the operational infrastructure supporting drug delivery in health systems.
Why It Stands Out in 2026: Pharmacy strategy sits at the intersection of some of the most consequential trends in health system decision-making right now: the financial and operational implications of 340B reform, the Inflation Reduction Act's drug pricing provisions, the growth of ambulatory infusion as a strategic service line, and the expanding role of pharmacy in value-based care transformation.
The Pharmacy Growth Collaborative brings health system pharmacy executives and select industry leaders together twice a year in a retreat-style setting designed for candid, peer-level exchange. Recent forum topics have covered evolving federal drug pricing reforms, the build-versus-partner decision in ambulatory infusion, biosimilar adoption strategy, and pharmacy's role in population health and total cost of care. The program maintains a 1:1 health system-to-industry ratio and limits participation to ensure conversations remain substantive. For cardiovascular-focused organizations, the Collaborative is particularly relevant given the deep overlap between cardiovascular drug management, specialty pharmacy infrastructure, and infusion care programs.
Best Suited For: Pharma commercial, market access, and field medical teams who need validated insight into how health system pharmacy leaders are approaching formulary governance, 340B strategy, and specialty drug utilization. Also relevant for health technology organizations whose solutions support pharmacy operations, ambulatory infusion, or medication management in a cardiovascular context.
THMA CPE Circle 2026
Dates and Location: Spring: May 11–13, 2026 | Fort Lauderdale, FL Fall: October 26–28, 2026 | Scottsdale, AZ
Who It Is For: Industry leaders whose solutions require physician executive sponsorship or depend on physician leadership adoption, including organizations in clinical AI, care delivery technology, workforce solutions, and strategic consulting whose go-to-market relies on alignment with system-level Chief Physician Executives.
Why It Stands Out in 2026: Independent Health System Chief Physician Executives occupy a uniquely influential position in health system leadership. They sit at the intersection of clinical quality, operational performance, and organizational strategy, and their support or skepticism toward a given solution often determines whether it gains traction across a health system. The CPE Circle is the only executive forum built specifically for this audience.
Held twice annually in a credentialed, retreat-style setting, the program gathers CPEs from independent and integrated health systems for peer-led discussions that surface the unfiltered realities of physician executive leadership in 2026. Current forum topics include AI governance and digital transformation leadership, the CFO-CPE relationship and shared frameworks for clinical ROI, systems thinking for managing organizational change, and the policy landscape surrounding Medicaid funding and value-based care accountability. The program carries continuing education accreditation alongside its peer learning format and maintains the same 1:1 health system-to-industry ratio that characterizes all THMA Executive Convening programs.
Best Suited For: Industry organizations whose solutions depend on physician executive alignment at the health system level, particularly those in clinical AI, care delivery transformation, physician workforce management, or strategic advisory services. Also relevant for cardiovascular-focused organizations whose sales or adoption cycle requires CPE sponsorship as a precondition for broader health system engagement.
ACC Annual Scientific Session 2026 (ACC.26)
Dates and Location: March 28–30, 2026 | New Orleans, LA (Ernest N. Morial Convention Center)
Who It Is For: The full spectrum of cardiovascular medicine stakeholders: cardiologists, interventionalists, cardiovascular surgeons, advanced practice providers, payers, health system administrators, and industry organizations with a cardiovascular commercial or research presence.
Why It Stands Out in 2026: ACC.26 is the flagship event of the American College of Cardiology and the single most concentrated gathering of cardiovascular science and clinical practice in the United States. Drawing roughly 15,000 attendees in a typical year, the Scientific Session serves as the primary venue for late-breaking clinical trial readouts, updated practice guidelines, and educational programming across disease areas including heart failure, atrial fibrillation, dyslipidemia, acute coronary syndromes, structural heart disease, and peripheral artery disease.
The 2026 edition in New Orleans encompasses the full range of formats: large-format plenary sessions, specialty symposia, abstract presentations, hands-on workshops, and an exhibition spanning cardiovascular devices, imaging technology, digital health, and pharmaceutical therapies. For industry organizations, the Scientific Session is where competitive intelligence, clinical context, and customer relationships converge at the start of the cardiovascular year.
Best Suited For: Any organization with a cardiovascular commercial footprint should treat ACC.26 as a mandatory spring presence. It is particularly essential for cardiovascular device companies, pharmaceutical and biotech organizations with CV pipelines or marketed therapies, imaging technology providers, and digital health companies whose solutions address cardiology workflows. Brand visibility, scientific dialogue, and stakeholder access are all available in a concentration that no other single event matches.
AHA Scientific Sessions 2026
Dates and Location: November 6–9, 2026 | Chicago, IL (McCormick Place)
Who It Is For: Cardiologists, cardiovascular researchers, basic scientists, clinical trialists, academic medical center leadership, and industry organizations with a cardiovascular research pipeline, a clinical evidence story to advance, or solutions that resonate with academic cardiovascular leadership.
Why It Stands Out in 2026: AHA Scientific Sessions is the second major pillar of the U.S. cardiovascular conference calendar alongside ACC, and its emphasis on research depth and academic reach makes it a distinct and complementary investment. The 2026 program at McCormick Place will feature late-breaking trials and featured science across heart failure, arrhythmia, hypertension, stroke, preventive cardiology, and vascular disease.
Where ACC tends to anchor the practice-changing data and guideline cycle, AHA is where the foundational science and emerging clinical evidence that will shape cardiovascular care in future years receives its most rigorous peer scrutiny. For industry organizations, the credentialed scientific audience at AHA provides a platform for evidence-based dialogue and thought leadership that is qualitatively different from the commercial orientation of earlier-year events. Closing the calendar year at AHA also allows industry teams to reenter planning cycles with a current read on the clinical science that will define cardiovascular strategy in 2027 and beyond.
Best Suited For: Organizations with a cardiovascular research pipeline, phase III data to position, or clinical evidence narratives that benefit from exposure to an academically oriented audience. Also valuable for industry organizations whose solutions are gaining traction in academic medical center cardiovascular programs and want to deepen engagement with the research and clinical leadership that drives academic adoption.
HIMSS26
Dates and Location: March 9–12, 2026 | Las Vegas, NV (Venetian Expo and Convention Center)
Who It Is For: Health system CIOs, CMIOs, chief digital officers, IT and data leaders, digital health companies, and industry organizations whose cardiovascular solutions depend on technology infrastructure, clinical data integration, or enterprise-level IT adoption.
Why It Stands Out in 2026: HIMSS26 is not a cardiology conference by design, but it is where the technology decisions that govern cardiovascular care delivery get made and negotiated. Drawing more than 28,000 attendees from 88 countries, including health system technology executives who determine what gets integrated into clinical workflows and enterprise infrastructure, HIMSS26 is the most concentrated access point to the IT and digital leadership layer of health systems.
The 2026 conference introduces a streamlined single-venue format, a new one-hour workshop program, a refreshed Emerge Experience connecting investors with digital health startups, and an Executive Summit for senior health system leadership. Programming spans AI implementation, interoperability, cybersecurity, data governance, and digital health transformation. For cardiovascular organizations, the relevance lies in the fact that AI-enabled imaging, remote monitoring platforms, clinical decision support tools, and cardiovascular data analytics all require the IT infrastructure and organizational alignment that HIMSS attendees govern.
Best Suited For: Cardiovascular technology and digital health organizations whose solutions depend on health system IT infrastructure, EHR integration, or enterprise data capabilities. HIMSS26 is a logical strategic complement to ACC.26 later in the same month, covering the technology adoption side of cardiovascular care to balance the clinical science coverage that ACC provides.
AONL 2026 Inspiring Leaders Conference
Dates and Location: March 29–April 1, 2026 | Chicago, IL (McCormick Place)
Who It Is For: Organizations whose cardiovascular solutions intersect with nursing leadership, care delivery operations, workforce management, or the clinical infrastructure that supports cardiovascular service lines within health systems.
Why It Stands Out in 2026: AONL is the largest nursing leadership conference in the United States, convening more than 4,000 CNOs, nurse executives, and frontline nursing leaders at McCormick Place. The 2026 theme, Inspiring Leaders, centers on innovation, workforce resilience, and the future of care delivery, with programming addressing AI adoption, staffing optimization, and care model redesign.
For cardiovascular-focused industry organizations, nursing leadership may not be the first conference constituency that comes to mind, but CNOs and nursing operations leaders govern staffing models for cardiac care units and catheterization labs, oversee remote monitoring care workflows, and hold significant influence over care protocol standardization and technology adoption decisions at the operational level. As cardiovascular nursing workforce shortages continue to challenge health systems, the operational and technological solutions that support CV nursing teams are gaining growing visibility at the C-suite level.
Best Suited For: Industry organizations in cardiovascular workforce management, staffing technology, care delivery platforms, remote monitoring, and patient care operations. AONL is particularly well-suited for organizations that have concentrated their conference presence on physician audiences and want to reach the nursing leadership stakeholders who often govern operational adoption of clinical technologies.
AHA Leadership Summit 2026
Dates and Location: July 12–14, 2026
Who It Is For: Industry organizations whose cardiovascular solutions are positioned at the health system strategy level and require engagement with C-suite leadership, including CEOs, COOs, CFOs, CMOs, CNOs, and CIOs who drive enterprise-level decisions.
Why It Stands Out in 2026: The AHA Leadership Summit is built explicitly for health system executive strategy, which distinguishes it from the scientific and technology conferences that dominate the spring calendar. The 2026 Summit is anchored by the theme "(Re)Designing Care Delivery and Operating Models for the Future" and is structured around shorter, interactive sessions designed to generate substantive peer exchange among senior leaders.
The attendee mix, which includes CEOs, COOs, CFOs, CMOs, CNOs, and CIOs from hospitals and health systems across the country, means that cardiovascular discussions at this event are framed in terms of service line economics, organizational redesign, and long-term capital and operational positioning rather than clinical science. The AHA Leadership Summit occupies a useful mid-year position in the calendar, bridging the intensive spring clinical season and the fall research cycle, and giving industry teams a genuine opportunity to engage the executive layer of health system leadership before the year's major strategic planning processes conclude.
Best Suited For: Industry organizations with cardiovascular solutions that carry a clear enterprise-level value proposition, including population health platforms, capital-intensive imaging or procedural technologies, AI solutions with system-wide application, and strategic advisory or consulting services. Also relevant for organizations whose commercial strategies require C-suite alignment before service line or clinical adoption can proceed.
What to Look for in a Cardiology Conference
The most useful framework for evaluating cardiology conferences in 2026 is not prestige or attendance size. Those metrics tell you how visible you will be, but they say very little about whether the right people will be in the room, whether the setting will produce meaningful conversation, or whether the time and cost will translate into outcomes that matter to your organization.
Audience Composition and Seniority
A conference populated primarily by fellows, residents, and mid-level clinicians will serve a different commercial purpose than one attended by cardiovascular service line chiefs, health system CMOs, or C-suite strategy executives. Before committing, examine who actually attends and in what capacity. Speaker lists and exhibitor rosters are useful proxies; so is asking peers in your organization who they have met at a given event in past years.
Format and Scale
Large conferences offer breadth and brand visibility, but they tend to compress interaction into brief exhibit hall encounters and scheduled meetings that feel transactional. Smaller, more intentional forums, particularly those with structured networking and peer-led sessions, create conditions for the kind of candid exchange that informs product development, commercial strategy, and partnership formation. The two types serve different purposes and are most valuable when used in combination.
Topical Alignment with the 2026 Landscape
Site-neutral payment reform, cardiovascular AI and predictive analytics, ambulatory growth and ASC strategy, and remote patient monitoring are the issues commanding the most executive attention this year. Events whose agendas reflect those priorities will generate more actionable intelligence than those whose programming has not caught up with the current landscape.
Relationship-Building Potential Beyond the Formal Program
Some conferences invest heavily in structured social programming, hosted dinners, and facilitated introductions that create genuine connections across the health system-industry divide. Others do not. The informal fabric of an event often determines whether relationships formed there deepen into something durable. When evaluating an event, it is worth asking not only what sessions are scheduled but what the environment around those sessions is designed to produce.
Building a Thoughtful 2026 Cardiology Conference Strategy
The conferences listed in this guide serve different purposes, and the most effective approach is to treat them as complementary layers of a single annual strategy rather than competing options. No single event addresses every audience, relationship objective, or intelligence need that a cardiovascular-focused industry organization carries into a given year.
The question worth asking at the planning stage is not how many conferences you can attend, but which combination of events will give you the broadest coverage of the people, relationships, and intelligence that your 2026 objectives require. For most cardiovascular-focused industry organizations, that answer includes at least one THMA Executive Convening program, both major clinical sessions, and one or two of the broader health system leadership events that extend your presence into the organizational infrastructure surrounding cardiovascular care.